Legacy Bridge, LLC Gilead Sciences, Inc. Transaction History

Legacy Bridge, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	BUY	$62.32 - $89.47 $22,061 - $31,672	354 New	354 $0
Q2 2022 Jul 21, 2022	SELL	$57.72 - $65.01 $8,369 - $9,426	-145 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$67.69 - $73.03 $15,907 - $17,162	-235 Reduced 61.84%	145 $10,000
Q2 2021 Aug 03, 2021	SELL	$63.47 - $69.35 $12,694 - $13,869	-200 Reduced 34.48%	380 $26,000
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $25,753 - $29,904	-356 Reduced 38.03%	580 $45,000
Q4 2019 Feb 04, 2020	SELL	$61.62 - $67.78 $102,843 - $113,124	-1,669 Reduced 64.07%	936 $61,000
Q3 2019 Oct 15, 2019	SELL	$62.51 - $69.0 $22,253 - $24,564	-356 Reduced 12.02%	2,605 $165,000
Q4 2018 Jan 25, 2019	BUY	$60.54 - $79.0 $179,258 - $233,919	2,961 New	2,961 $185,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Legacy Bridge, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Bridge, LLC with notifications on news.